21 related articles for article (PubMed ID: 1593909)
1. Predicting Drug Synergy and Discovering New Drug Combinations Based on a Graph Autoencoder and Convolutional Neural Network.
Li H; Zou L; Kowah JAH; He D; Wang L; Yuan M; Liu X
Interdiscip Sci; 2023 Jun; 15(2):316-330. PubMed ID: 36943614
[TBL] [Abstract][Full Text] [Related]
2. Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.
Leung G; Papademetriou M; Chang S; Arena F; Katz S
Curr Treat Options Gastroenterol; 2016 Dec; 14(4):507-534. PubMed ID: 27709332
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.
Dunn CJ; Goa KL
Drugs Aging; 1996 Aug; 9(2):122-47. PubMed ID: 8820798
[TBL] [Abstract][Full Text] [Related]
4. Effects of amsacrine in combination with other anticancer agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Sakamoto S; Kasahara T; Akutsu M; Inoue Y; Miura Y
Leuk Res; 1991; 15(11):1059-66. PubMed ID: 1961009
[TBL] [Abstract][Full Text] [Related]
5. Effects of CPT-11 in combination with other anti-cancer agents in culture.
Kano Y; Suzuki K; Akutsu M; Suda K; Inoue Y; Yoshida M; Sakamoto S; Miura Y
Int J Cancer; 1992 Feb; 50(4):604-10. PubMed ID: 1537625
[TBL] [Abstract][Full Text] [Related]
6. Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines.
Kano Y; Akutsu M; Suzuki K; Yoshida M
Leuk Res; 1993 Feb; 17(2):113-9. PubMed ID: 8429687
[TBL] [Abstract][Full Text] [Related]
7. The effects of ICRF-154 in combination with other anticancer agents in vitro.
Kano Y; Narita T; Suzuki K; Akutsu M; Suda K; Sakamoto S; Miura Y
Br J Cancer; 1992 Aug; 66(2):281-6. PubMed ID: 1503899
[TBL] [Abstract][Full Text] [Related]
8. [Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
Akutsu M; Suzuki K; Tsunoda S; Kano Y
Gan To Kagaku Ryoho; 1996 Feb; 23(3):297-302. PubMed ID: 8712822
[TBL] [Abstract][Full Text] [Related]
9. Rational approach to the clinical protocol design for drug combinations: a review.
Chang TT; Chou TC
Acta Paediatr Taiwan; 2000; 41(6):294-302. PubMed ID: 11198934
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant drug-drug interactions in oncology.
McLeod HL
Br J Clin Pharmacol; 1998 Jun; 45(6):539-44. PubMed ID: 9663808
[TBL] [Abstract][Full Text] [Related]
11. Effects of mitoxantrone in combination with other anticancer agents on a human leukemia cell line.
Kano Y; Suzuki K; Akutsu M; Suda K
Leukemia; 1992 May; 6(5):440-5. PubMed ID: 1593909
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
